» Articles » PMID: 36384135

IKKβ Primes Inflammasome Formation by Recruiting NLRP3 to the Trans-Golgi Network

Abstract

The NLRP3 inflammasome plays a central role in antimicrobial defense as well as in the context of sterile inflammatory conditions. NLRP3 activity is governed by two independent signals: the first signal primes NLRP3, rendering it responsive to the second signal, which then triggers inflammasome formation. Our understanding of how NLRP3 priming contributes to inflammasome activation remains limited. Here, we show that IKKβ, a kinase activated during priming, induces recruitment of NLRP3 to phosphatidylinositol-4-phosphate (PI4P), a phospholipid enriched on the trans-Golgi network. NEK7, a mitotic spindle kinase that had previously been thought to be indispensable for NLRP3 activation, was redundant for inflammasome formation when IKKβ recruited NLRP3 to PI4P. Studying iPSC-derived human macrophages revealed that the IKKβ-mediated NEK7-independent pathway constitutes the predominant NLRP3 priming mechanism in human myeloid cells. Our results suggest that PI4P binding represents a primed state into which NLRP3 is brought by IKKβ activity.

Citing Articles

Isocyanic acid-mediated NLRP3 carbamoylation reduces NLRP3-NEK7 interaction and limits inflammasome activation.

Zhang Z, Chen C, Liu C, Sun P, Liu P, Fang S Sci Adv. 2025; 11(10):eadq4266.

PMID: 40053593 PMC: 11887815. DOI: 10.1126/sciadv.adq4266.


TBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways.

Fischer F, Demarco B, Min F, Yeap H, De Nardo D, Chen K Sci Adv. 2025; 11(10):eadq1047.

PMID: 40053580 PMC: 11887814. DOI: 10.1126/sciadv.adq1047.


PRRSV-2 nsp2 Ignites NLRP3 inflammasome through IKKβ-dependent dispersed trans-Golgi network translocation.

Zhang L, Gao Y, Zhou H, Liang X, Jiang X, Gong W PLoS Pathog. 2025; 21(1):e1012915.

PMID: 39869629 PMC: 11801707. DOI: 10.1371/journal.ppat.1012915.


NIS-Seq enables cell-type-agnostic optical perturbation screening.

Fandrey C, Jentzsch M, Konopka P, Hoch A, Blumenstock K, Zackria A Nat Biotechnol. 2024; .

PMID: 39702735 DOI: 10.1038/s41587-024-02516-5.


Updated insights into the NLRP3 inflammasome in postoperative cognitive dysfunction: emerging mechanisms and treatments.

Wang T, Sun G, Tao B Front Aging Neurosci. 2024; 16:1480502.

PMID: 39411285 PMC: 11474915. DOI: 10.3389/fnagi.2024.1480502.


References
1.
Hornung V, Latz E . Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J Immunol. 2010; 40(3):620-3. PMC: 3893565. DOI: 10.1002/eji.200940185. View

2.
Cavlar T, Deimling T, Ablasser A, Hopfner K, Hornung V . Species-specific detection of the antiviral small-molecule compound CMA by STING. EMBO J. 2013; 32(10):1440-50. PMC: 3655471. DOI: 10.1038/emboj.2013.86. View

3.
Posor Y, Jang W, Haucke V . Phosphoinositides as membrane organizers. Nat Rev Mol Cell Biol. 2022; 23(12):797-816. PMC: 9117997. DOI: 10.1038/s41580-022-00490-x. View

4.
Coll R, Robertson A, Chae J, Higgins S, Munoz-Planillo R, Inserra M . A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015; 21(3):248-55. PMC: 4392179. DOI: 10.1038/nm.3806. View

5.
Sanjana N, Shalem O, Zhang F . Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014; 11(8):783-784. PMC: 4486245. DOI: 10.1038/nmeth.3047. View